(Q38098260)

28 August 2017

Combination therapy in the management of pulmonary arterial hypertension (English)

1 reference

28 August 2017

M S Buckley

1

1 reference

PubMed ID

23578069

28 August 2017

R L Staib

series ordinal

2

1 reference

PubMed ID

23578069

28 August 2017

L M Wicks

series ordinal

3

1 reference

28 August 2017

1 May 2013

1 reference

International journal of clinical practice. Supplement

28 August 2017

1 reference

28 August 2017

179

1 reference

28 August 2017

13-23

1 reference

Updated evidence-based treatment algorithm in pulmonary arterial hypertension.

28 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Updated clinical classification of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Cellular and molecular pathobiology of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Additional effects of bosentan in patients with idiopathic pulmonary arterial hypertension already treated with high-dose epoprostenol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Oral sildenafil improves primary pulmonary hypertension refractory to epoprostenol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Bosentan improves exercise tolerance and Tei index in patients with pulmonary hypertension and prostanoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Acute hemodynamic effects of single-dose sildenafil when added to established bosentan therapy in patients with pulmonary arterial hypertension: results of the COMPASS-1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Tadalafil therapy for pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Goal-oriented treatment and combination therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJCP.12136

21 January 2018

Identifiers

DOI

10.1111/IJCP.12136

1 reference

28 August 2017

1 reference

PubMed ID

23578069